You are here

teplizumab

FDA greenlights Provention Bio's diabetes drug

Yahoo/Reuters

Fri, 11/18/22 - 10:22 am

type 1 diabetes

Anticipating FDA Yes, Provention Inks Co-Promotion Deal with Sanofi for T1D Drug

BioSpace

Thu, 10/6/22 - 07:07 pm

type 1 diabetes

Provention’s embattled diabetes med delayed again by FDA to consider new info

Fierce Biotech

Thu, 06/30/22 - 10:15 pm

FDA sets August decision date for Provention’s type 1 diabetes drug

Pharmaforum

Mon, 03/21/22 - 10:15 am

type 1 diabetes

Provention will wait for FDA to 'opine' on new data after teplizumab rejection, eyes Q4 for further talks

Fierce Biotech

Mon, 09/13/21 - 10:38 am

type 1 diabetes

Provention Bio slapped with FDA rejection for diabetes hopeful teplizumab

Fierce Biotech

Tue, 07/6/21 - 10:58 am

type 1 diabetes

complete response letter

FDA Action Alert: Vericel and Provention Bio

BioSpace

Mon, 06/28/21 - 06:51 pm

type 1 diabetes

FDA adcomm votes in favor of approving Provention Bio’s drug to delay type 1 diabetes

Endpoints

Thu, 05/27/21 - 11:57 pm

type 1 diabetes

Provention Bio, in need of AdComm's support for diabetes drug, may have what it needs to satisfy the FDA

Fierce Biotech

Tue, 05/25/21 - 11:52 pm

advisory panels

Provention warns FDA requests could delay diabetes approval

Fierce Biotech

Fri, 04/9/21 - 10:46 am

type 1 diabetes

Provention Bio gives update on teplizumab BLA, FDA feedback

Seeking Alpha

Thu, 04/8/21 - 07:34 pm

type 1 diabetes

Can A Drug That Delays The Onset Of Type 1 Diabetes Be A Success?

Forbes

Tue, 06/25/19 - 07:23 pm

type 1 diabetes

Eight years after Eli Lilly dumped it, an upstart biotech has nabbed teplizumab and filed a $56M IPO to back a PhIII comeback

Endpoints

Thu, 05/10/18 - 11:02 pm

Lilly, MacroGenics Say Diabetes Treatment Misses Goal in Late-Stage Study

Bloomberg

Wed, 10/20/10 - 09:38 pm

Lilly licenses PDL type 1 diabetes drug candidate

Yahoo/AP

Tue, 12/22/09 - 07:53 am

type 1 diabetes